PCSK9 and coronary artery disorder: Since PCSK9 interferes with the clearance of LDL-C from the blood, its loss-of-function mutations are associated with up to 85% lower plasma LDL-C levels9 and offer significant protection from coronary artery disease (CAD), like atherosclerosis10.